Scripps VIVO scripps research logo

  • Index
  • Log in
  • Home
  • People
  • Organizations
  • Research
  • Events
Search form

Therapeutic strategies for human amyloid diseases

Academic Article
uri icon
  • Overview
  • Identity
  • Additional Document Info
  • View All
scroll to property group menus

Overview

authors

  • Sacchettini, J. C.
  • Kelly, Jeffery

publication date

  • 2002

journal

  • Nature Reviews Drug Discovery  Journal

abstract

  • Amyloid diseases are a large group of a much larger family of misfolding diseases. This group includes pathologies as diverse as Alzheimer's disease, immunoglobulin-light-chain disease, reactive amyloid disease and the familial amyloid polyneuropathies. These diseases are generally incurable at present, although some drugs are known to transiently slow the progression of Alzheimer's disease. As we increase our understanding of the causative mechanisms of these disorders, the likelihood of success for a given therapeutic strategy will become clearer. This review will look at small-molecule and macromolecular approaches for intervention in amyloid diseases other than Alzheimer's disease, although select examples from Alzheimer's disease will be discussed.

subject areas

  • Alzheimer Disease
  • Amyloid
  • Amyloid Neuropathies, Familial
  • Amyloidosis
  • Humans
  • Immunization
  • Risk Factors
scroll to property group menus

Identity

International Standard Serial Number (ISSN)

  • 1474-1776

Digital Object Identifier (DOI)

  • 10.1038/nrd769

PubMed ID

  • 12120278
scroll to property group menus

Additional Document Info

start page

  • 267

end page

  • 275

volume

  • 1

issue

  • 4

©2019 The Scripps Research Institute | Terms of Use | Powered by VIVO

  • About
  • Contact Us
  • Support